Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Avelumab +1 More for Cancer
Recruiting3 awardsPhase 2
Houston, Texas
This trial studies how well axitinib and avelumab work together in treating patients with adenoid cystic carcinoma that has returned or spread. Axitinib blocks enzymes needed for cancer growth, while avelumab helps the immune system attack the cancer. The goal is to see if this combination can better control the disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service